Business
Positive data for COVID-19 antigen test
Positive data for COVID-19 antigen test.
About this update from Cambridge Nutritional Sciences Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 3095A\n Omega Diagnostics Group PLC\n 01 June 2021\n \n \n \n \n OMEGA DIAGNOSTICS GROUP PLC \n \n \n (\"Omega\" or the \"Company\" or the \"Group\")\n \n \n \n \n \n Positive study data for Mologic COVID-19 lateral flow antigen test\n \n \n \n Test shows high diagnostic accuracy (\n \n specificity and sensitivity) exceeding WHO targets\n \n \n \n \n \n Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes the publication of a manuscript entitled: \n \"Accuracy of the Mologic COVID-19 rapid antigen test: a prospective multi-centre analytical and clinical evaluation\" which provides \n positive study data relating to Mologic Ltd's ('Mologic') lateral flow antigen test for COVID-19.\n \n \n \n \n \n The study concludes that the Mologic test, which has been commercialized by Omega as the \n \n \n VISITECT® COVID-19 Antigen test\n \n \n , has fulfilled the WHO target diagnostic accuracy with a high sensitivity (93.2%-98.4%) detecting individuals with high viral load infections (Ct<20 and Ct<25). \n \n \n \n \n \n The VISITECT® COVID-19 Antigen test provides healthcare professionals with an accurate rapid test for the detection of the nucleoprotein of the SARS-CoV-2 virus in respiratory swabs in 10 minutes. \n \n \n \n \n \n \n The Mologic COVID-19 rapid test was evaluated in a prospective multicentre study across UK sites, where a total of 347 participants were enrolled. The Diagnostic accuracy and clinical performance of the test were investigated by comparing to gold standard RT-PCR results from individuals with and without COVID-19 symptoms attending secondary care facilities in Merseyside, ambulance services in Yorkshire, and drive-through testing facilities in Northumberland, UK.\n \n \n \n \n \n With data stratified by RT-PCR cycle threshold (Ct), sensitivity was shown to be high in individuals with highest viral loads (i.e. most likely to be highly contagious): 93.2% of samples with a Ct less than 25 and 98.4% of samples with a Ct less than 20. Overall sensitivity (including all cycle thresholds, so individuals with low viral loads as well) and specificity compared to the reference SARS-CoV-2 RT-PCR was 85.0% and 97.8% respectively.\n \n \n \n \n \n The study also concluded...